Citation Impact
Citing Papers
Transcriptional Regulation by Nrf2
2017 Standout
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
2005
NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer
2009 Standout
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
Risk Stratification After Coronary Artery Bypass Surgery by a Point-of-Care Test of Platelet Function
2009
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
2005
The bovine thromboxane A2 receptor: molecular cloning, expression, and functional characterization
1997
The Society of Thoracic Surgeons Practice Guideline Series: Aspirin and Other Antiplatelet Agents During Operative Coronary Revascularization (Executive Summary)*
2005
Nrf2–Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species
2006 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Controversies in Oral Antiplatelet Therapy in Patients Undergoing Aortocoronary Bypass Surgery
2010
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
2008
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Pharmacology of Antiplatelet Agents
2013
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology
2010
Indirect comparison meta-analysis of aspirin therapy after coronary surgery
2003
Vascular injury and modulation of MAPKs: A targeted approach to therapy of restenosis
2007
A Role for Uric Acid in the Progression of Renal Disease
2002 Standout
Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer
2006 Standout
Autologous platelets as a source of proteins for healing and tissue regeneration
2003 Standout
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
Platelet Surface Membranes Are Highly Mitogenic for Coronary Artery Smooth Muscle Cells–A Novel Mechanism for Sustained Proliferation after Vessel Injury?
1999
Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage
2012
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
2005
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Aspirin resistance
2006
Suppression of Rat Thromboxane Synthase Gene Transcription by Peroxisome Proliferator-activated Receptor γ in Macrophages via an Interaction with NRF2
2000
The genetics of antiplatelet drug resistance
2008
Aprotinin Shows Both Hemostatic and Antithrombotic Effects During Off-Pump Coronary Artery Bypass Grafting
2005
Atrial Fibrillation Ablation: Reaching the Mainstream
2006
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
The Role of Aspirin in Cardiovascular Prevention
2008
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
2009 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Narrative Review: Aspirin Resistance and Its Clinical Implications
2005
Cardiovascular Effects of the Cyclooxygenase Inhibitors
2007
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling
2017 Standout
Aspirin Resistance and Atherothrombotic Disease
2005
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-α– and Angiotensin II–Mediated Proliferation of Vascular Smooth Muscle Cells
2000
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Progress on the Mechanism for Aspirin’s Anti-tumor Effects
2020
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Works of A.-A. Weber being referenced
Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth
2001
Pharmakologie von Ticlopidin und Clopidogrel im Vergleich zu Acetylsalicylsäure
1997
Aspirin resistance after coronary artery bypass grafting
2001
Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery
2003
Thrombin-Induced Mitogenesis in Coronary Artery Smooth Muscle Cells Is Potentiated by Thromboxane A2and Involves Upregulation of Thromboxane Receptor mRNA
1998